Skip to content

Improving Adherence to Postpartum Family Planning Guidance in Ghana

Improving Adherence to Postpartum Family Planning Guidance in Ghana: a Hybrid Type 2 Implementation and Effectiveness Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04306029
Enrollment
2142
Registered
2020-03-12
Start date
2020-02-24
Completion date
2021-11-16
Last updated
2022-01-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Contraception

Brief summary

Evaluating a Postpartum Family Planning Package (PPFP) in a Hybrid Type II implementation study with a stepped-wedge design.

Detailed description

Our overarching goal is to enable providers to consistently offer and deliver highly effective postpartum family planning methods in accordance with international guidelines. Our primary objective in this research is to assess the implementation and effectiveness of the Postpartum Family Planning Package (PFPP), an implementation strategy that consists of the following components: 1) a provider training on contraceptive methods available in the immediate postpartum period, and techniques for their placement in the case of intrauterine devices and implants, with quarterly booster trainings, and 2) promotion of the WHO MEC/Postpartum Family Planning Compendium mobile application as a provider decision tool to aid in postpartum family planning counselling.

Interventions

OTHERPostpartum Family Planning Package

Postpartum Family Planning Package, which consists of provider education on contraceptive delivery in the immediate postpartum period and promotion of the WHO MEC/PFP Compendium mobile application.

Sponsors

World Health Organization
CollaboratorOTHER
University of Ghana
CollaboratorOTHER
University of Pennsylvania
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
SEQUENTIAL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE

Intervention model description

Hybrid Type II implementation and effectiveness study using a quasi-experimental stepped-wedge design.

Eligibility

Sex/Gender
FEMALE
Healthy volunteers
No

Inclusion criteria

Provider Inclusion Criteria: * Providers who care for postpartum women on the inpatient postpartum ward, including midwives, nurses, residents, fellows, and consultant physicians. Provider

Exclusion criteria

* Students caring for postpartum patients on the postpartum ward. Client Inclusion Criteria: \- Women receiving antenatal care who have the potential to be admitted to the inpatient postpartum ward following delivery, or women admitted in the postpartum ward. Client

Design outcomes

Primary

MeasureTime frame
Provider discussed all guideline-appropriate contraceptive methods as defined by World Health Organization Medical Eligibility Criteria (yes/no)During postpartum inpatient stay, prior to hospital discharge (approximately 2 days)

Countries

Ghana

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026